Bernd Brust has bought MRVI on 2 days since Nov 2025
CEO at Maravai LifeSciences Holdings, Inc.
SEC CIK 0001380632 · Filings on SEC.gov ↗
Bernd Brust's record
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Every filing
2 filings since Nov 2025, newest first
About Bernd Brust
Bernd Brust is the Chief Executive Officer and Director of Maravai LifeSciences Holdings, Inc. (MRVI), appointed in June 2025.( With over 30 years of global leadership in life sciences and scientific instrumentation, he specializes in commercial operations, strategic growth, and innovation.(
Previously, Brust served as Executive Chairman (2021-2025) and CEO of Antylia Scientific, leading its growth and sale to Brookfield Asset Management for $1.3 billion.( He was President and CEO of Qualicaps, acquired by Mitsubishi Chemical Holdings in 2013, and Chief Commercial Operations Officer at Life Technologies Corporation, overseeing a $3.5 billion global business.( Earlier roles include Senior Vice President of Global Sales & Marketing at Invitrogen Corporation (2004-2008) and General Manager of Sales & Marketing at GE Medical Systems Information Technologies.( He holds an undergraduate degree from the University of Amsterdam.( Brust also serves as Chairman & CEO of Cole-Parmer Instrument Co. (since 2014) and Director at organizations like San Diego Regional Chamber of Commerce and BIOCOM.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.